Ganga Pharmaceuticals (BOM:539680) Total Liabilities : ₹19.35 Mil (As of Sep. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Ganga Pharmaceuticals Total Liabilities?

Ganga Pharmaceuticals's Total Liabilities for the quarter that ended in Sep. 2024 was ₹19.35 Mil.

Ganga Pharmaceuticals's quarterly Total Liabilities declined from Sep. 2023 (₹23.33 Mil) to Mar. 2024 (₹15.95 Mil) but then increased from Mar. 2024 (₹15.95 Mil) to Sep. 2024 (₹19.35 Mil).

Ganga Pharmaceuticals's annual Total Liabilities declined from Mar. 2022 (₹25.84 Mil) to Mar. 2023 (₹25.34 Mil) and declined from Mar. 2023 (₹25.34 Mil) to Mar. 2024 (₹15.95 Mil).

Ganga Pharmaceuticals Total Liabilities Historical Data

The historical data trend for Ganga Pharmaceuticals's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ganga Pharmaceuticals Total Liabilities Chart

Ganga Pharmaceuticals Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Total Liabilities

Get a 7-Day Free Trial

22.15

22.87

25.84

25.34

15.95

Ganga Pharmaceuticals Semi-Annual Data
	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24	Sep24
Total Liabilities	Get a 7-Day Free Trial															26.94	25.34	23.33	15.95	19.35

Ganga Pharmaceuticals Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Ganga Pharmaceuticals's Total Liabilities for the fiscal year that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	11.955	+	(3.948	+	0.046999999999999
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	15.95

Total Liabilities	=	Total Assets (A: Mar. 2024 )	-	Total Equity (A: Mar. 2024 )
	=	86.476	-	70.526
	=	15.95

Ganga Pharmaceuticals's Total Liabilities for the quarter that ended in Sep. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	14.169	+	(5.088	+	0.089
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	19.35

Total Liabilities	=	Total Assets (Q: Sep. 2024 )	-	Total Equity (Q: Sep. 2024 )
	=	90.112	-	70.766
	=	19.35

Ganga Pharmaceuticals Total Liabilities Related Terms

Thank you for viewing the detailed overview of Ganga Pharmaceuticals's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Ganga Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ganga Pharmaceuticals Ltd (BOM:539680) » Definitions » Total Liabilities

Traded in Other Exchanges

N/A

Address

Dhanvantri Marg, Gangatat, Gopcharpada, Near Digi 1 Electronic Showroom, Virar (East), Palghar, MH, IND, 401305

Website

https://www.ayurvedganga.com

Ganga Pharmaceuticals Ltd is an India based producer of ayurvedic medicines. It is engaged in the business of manufacturing and trading in ayurvedic pharmaceuticals and allied products. The company is also involved in the marketing and distribution of bulk ayurvedic medicines. The firm offers ayurvedic medicines for acidity, anti-dandruff, anti-oxidants, dental care, diarrhea, iron tonic, liver disorder, weight management, kidney stone, joint pains, liver disorder and others.

Ganga Pharmaceuticals Headlines

No Headlines